NATZOLD 5MG INFUSION

About NATZOLD 5MG INFUSION

NATZOLD 5MG INFUSION contains Zoledronic Acid which belongs to the group of medicines called Bisphosphonates. NATZOLD 5MG INFUSION is used in post-menopausal women and adult men to treat osteoporosis or osteoporosis caused by treatment with corticosteroids and Pagets disease of the bone in adults.Osteoporosis is a bone disease that develops when bone mineral density and bone mass decreases or when the quality or structure of the bone changes. It usually occurs in women after the menopause and also occurs in adult men. Paget's disease of bone is a chronic bone disorder which disrupts the normal cycle of bone renewal, causing bones to become weakened and possibly deformed.Along treatment with NATZOLD 5MG INFUSION your doctor might ask you to make some lifestyle changes such as eating balanced diet rich in calcium and vitamin D. Prior to starting the treatment with NATZOLD 5MG INFUSION your doctor might want you to take some diagnostic tests to understand the existing condition.NATZOLD 5MG INFUSION is not recommended for use in patients with severe kidney problems and hypocalcemia (low levels of calcium in the blood). NATZOLD 5MG INFUSION is not recommended for use in pregnant and breastfeeding women. Consult your doctor before receiving NATZOLD 5MG INFUSION.NATZOLD 5MG INFUSION is not recommended for use in children and adolescents (under 18 years of age) and should be used with caution in elderly patients. The most common side effects of receiving NATZOLD 5MG INFUSION are headache, dizziness, vomiting, diarrhoea, fever, chills, pain in muscles, joints or bones and pain in back, arms or legs. Inform your doctor if any of the symptom worsens. ..

Comprehensive Treatment for Bone Health

NATZOLD 5MG INFUSION serves as an advanced bisphosphonate therapy for adults dealing with bone-related disorders. By directly inhibiting bone breakdown, it reinforces bone structure and reduces risks associated with osteoporosis, Paget's disease, and bone complications from cancer.


Precise Dosage and Safe Administration

The product is available in a glass vial, intended for a single-use infusion of 5 mg Zoledronic Acid in 100 mL. Administration is strictly intravenous, performed in a clinical setting by qualified healthcare providers over a duration of at least 15 minutes.


Strict Safety and Storage Guidelines

For optimal efficacy and stability, NATZOLD should be stored below 30C and shielded from light. The product must never be frozen. Healthcare professionals should regularly monitor renal function and calcium levels during the course of treatment.